![Mayur Somaiya](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 2 M $ in data 30/06/2026
Mayur Ian Somaiya is currently Chief Financial Officer at NewAmsterdam Pharma Co. NV since 2023.
Former roles include Managing Director & Senior Research Analyst at Piper Sandler & Co. (2010–2013), Managing Director at Thomas Weisel Partners LLC (2003–2009), Managing Director & Senior Analyst at Nomura Securities International, Inc. (2013–2016), Managing Director & Analyst at BMO Capital Markets Corp.
(2016–2018), Managing Director at Piper Sandler Cos., Analyst at Prudential Securities (1997–1999), Senior Analyst at Morgan Stanley & Co. LLC (2000–2002), Consultant at Carson Group, Inc. (New York) (1996–1997), Chief Financial Officer at TCR² Therapeutics, Inc. (2018–2021), and Chief Financial & Business Officer at Elucida Oncology, Inc. (2021–2023).
Education includes an undergraduate degree from New York University, conferred in 1995.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 21/01/2026 | 58.382 ( 0,05% ) | 2 M $ | 30/06/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| FRAZIER LIFESCIENCES ACQUISITION CORPORATION | Direttore Finanziario/CFO | 23/10/2023 |
| Società | Posizione | Fine |
|---|---|---|
Elucida Oncology, Inc.
 Elucida Oncology, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which focuses on clinical research and development | Direttore Finanziario/CFO | 01/07/2023 |
| TCR2 THERAPEUTICS INC. | Direttore Finanziario/CFO | 10/12/2021 |
BMO Capital Markets Corp. (Broker)
 BMO Capital Markets Corp. (Broker) Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 01/04/2018 |
Nomura Securities International, Inc.
 Nomura Securities International, Inc. Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 01/01/2016 |
Piper Sandler & Co. (Broker)
 Piper Sandler & Co. (Broker) Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 31/10/2013 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 12 |
|---|---|
Prudential Securities
 Prudential Securities Investment Banks/BrokersFinance Provides brokerage services | Finance |
Piper Sandler & Co. (Broker)
Piper Sandler & Co. (Broker) Investment Banks/BrokersFinance Provides brokerage services | Finance |
Morgan Stanley & Co. LLC
 Morgan Stanley & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Thomas Weisel Partners LLC
 Thomas Weisel Partners LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Carson Group, Inc. (New York)
 Carson Group, Inc. (New York) Investment ManagersFinance Provides financial advisory and investment services | Finance |
Nomura Securities International, Inc.
Nomura Securities International, Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
New York University
 New York University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BMO Capital Markets Corp. (Broker)
BMO Capital Markets Corp. (Broker) Investment Banks/BrokersFinance Provides brokerage services | Finance |
TCR2 Therapeutics, Inc.
 TCR2 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage cell therapy company which engages in the development of biological drugs and engineering T-cells for cancer therapy | Health Technology |
Elucida Oncology, Inc.
Elucida Oncology, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which focuses on clinical research and development | Health Technology |
Piper Sandler Cos.
 Piper Sandler Cos. Investment Banks/BrokersFinance Provides investment banking and financial services | Finance |
NewAmsterdam Pharma Co. NV
 NewAmsterdam Pharma Co. NV Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that researches, develops, manufactures and commercializes transformative therapies for cardio-metabolic diseases | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
